Covered recipient · General Payments record
BINITA R SHAH
Allopathic & Osteopathic Physicians Emergency Medicine Pediatric Emergency Medicine
General Payments · PY2018–2024
$43,963.56
- Reported across 13 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $28,013.50 | 4 |
| Travel and Lodging | $15,381.53 | 3 |
| Food and Beverage | $330.07 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $30,581.55 | 5 |
| Novo Nordisk AS | $13,094.75 | 3 |
| Seqirus USA Inc | $48.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | $589.88 | 05/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096551929 | CMS |
| Novo Nordisk AS | $14,539.40 | 05/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096552631 | CMS |
| Novo Nordisk AS | $281.27 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096552633 | CMS |
| Novo Nordisk AS | $252.25 | 05/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1096552677 | CMS |
| Novo Nordisk AS | $14,918.75 | 05/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1096553015 | CMS |
| Novo Nordisk Inc | $6,237.00 | 09/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097322823 | CMS |
| Novo Nordisk Inc | $3,564.00 | 09/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097838575 | CMS |
| Novo Nordisk Inc | $3,293.75 | 11/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097498694 | CMS |
| Seqirus USA Inc | $48.80 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125627001 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.